According to the global mammalian polyclonal IgG antibody market report by IMARC Group, the market reached a value of US$ 984.81 Million in 2021, and it is projected to reach a value of US$ 1,351.73 Million by 2027, exhibiting a CAGR of 5.25% during 2022-2027. Mammalian polyclonal immunoglobulins (IgG) antibodies are antigens or vaccines made by inoculating numerous mammals, such as...